Scott SA - Search Results

1

Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.

Pratt VM, Everts RE, Aggarwal P, Beyer BN, Broeckel U, Epstein-Baak R, Hujsak P, Kornreich R, Liao J, Lorier R, Scott SA, Smith CH, Toji LH, Turner A, Kalman LV. Pratt VM, et al. Among authors: scott sa. J Mol Diagn. 2016 Jan;18(1):109-23. doi: 10.1016/j.jmoldx.2015.08.005. Epub 2015 Nov 24. J Mol Diagn. 2016. PMID: 26621101 Free PMC article.

2

CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.

Scott SA, Edelmann L, Kornreich R, Erazo M, Desnick RJ. Scott SA, et al. Pharmacogenomics. 2007 Jul;8(7):721-30. doi: 10.2217/14622416.8.7.721. Pharmacogenomics. 2007. PMID: 18240905

3

Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.

Scott SA, Edelmann L, Kornreich R, Desnick RJ. Scott SA, et al. Am J Hum Genet. 2008 Feb;82(2):495-500. doi: 10.1016/j.ajhg.2007.10.002. Epub 2008 Jan 17. Am J Hum Genet. 2008. PMID: 18252229 Free PMC article.

4

CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.

Scott SA, Jaremko M, Lubitz SA, Kornreich R, Halperin JL, Desnick RJ. Scott SA, et al. Pharmacogenomics. 2009 Aug;10(8):1243-55. doi: 10.2217/pgs.09.71. Pharmacogenomics. 2009. PMID: 19663669 Free PMC article.

5

Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups.

Scott SA, Khasawneh R, Peter I, Kornreich R, Desnick RJ. Scott SA, et al. Pharmacogenomics. 2010 Jun;11(6):781-91. doi: 10.2217/pgs.10.49. Pharmacogenomics. 2010. PMID: 20504253 Free PMC article.

6

Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.

Scott SA, Edelmann L, Liu L, Luo M, Desnick RJ, Kornreich R. Scott SA, et al. Hum Mutat. 2010 Nov;31(11):1240-50. doi: 10.1002/humu.21327. Hum Mutat. 2010. PMID: 20672374 Free PMC article.

7

Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness.

Scott SA, Martis S, Peter I, Kasai Y, Kornreich R, Desnick RJ. Scott SA, et al. Pharmacogenomics J. 2012 Aug;12(4):297-305. doi: 10.1038/tpj.2011.5. Epub 2011 Mar 1. Pharmacogenomics J. 2012. PMID: 21358751 Free PMC article.

8

Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes.

Martis S, Peter I, Hulot JS, Kornreich R, Desnick RJ, Scott SA. Martis S, et al. Among authors: scott sa. Pharmacogenomics J. 2013 Aug;13(4):369-77. doi: 10.1038/tpj.2012.10. Epub 2012 Apr 10. Pharmacogenomics J. 2013. PMID: 22491019 Free PMC article.

9

Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy.

Lyon E, Gastier Foster J, Palomaki GE, Pratt VM, Reynolds K, Sábato MF, Scott SA, Vitazka P; working group of the Molecular Genetics Subcommittee on behalf of the American College of Medical Genetics and Genomics ACMG) Laboratory Quality Assurance Committee. Lyon E, et al. Among authors: scott sa. Genet Med. 2012 Dec;14(12):990-1000. doi: 10.1038/gim.2012.108. Epub 2012 Sep 6. Genet Med. 2012. PMID: 22955113 Free article. Review.

10

Multi-ethnic cytochrome-P450 copy number profiling: novel pharmacogenetic alleles and mechanism of copy number variation formation.

Martis S, Mei H, Vijzelaar R, Edelmann L, Desnick RJ, Scott SA. Martis S, et al. Among authors: scott sa. Pharmacogenomics J. 2013 Dec;13(6):558-66. doi: 10.1038/tpj.2012.48. Epub 2012 Nov 20. Pharmacogenomics J. 2013. PMID: 23164804 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters